['A number of brokerages recently weighed in on RCM. Bank of America began coverage on shares of R1 RCM in a report on Thursday, July 22nd. They set a “buy” rating and a $27.00 target price on the stock. Barclays initiated coverage on shares of R1 RCM in a research report on Thursday, September 30th. They set an “overweight” rating and a $28.00 price objective for the company. Robert W. Baird  reaffirmed a “buy” rating on shares of R1 RCM in a research report on Thursday, August 19th. JPMorgan Chase & Co. initiated coverage on shares of R1 RCM in a research report on Thursday, October 14th. They set an “overweight” rating and a $27.00 price objective for the company. Finally, Zacks Investment Research raised shares of R1 RCM from a “hold” rating to a “buy” rating and set a $27.00 price objective for the company in a research report on Thursday. Ten investment analysts have rated the stock with a buy rating,  According to MarketBeat.com, the company currently has an average rating of “Buy” and an average price target of $28.20.', '\n\n\n\n\n\n                 In related news, CEO Joseph Gerard Flanagan sold 30,699 shares of the stock in a transaction on Wednesday, October 13th. The stock was sold at an average price of $23.07, for a total value of $708,225.93. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Richard B. Jr. Evans sold 7,000 shares of the firm’s stock in a transaction on Thursday, August 12th. The shares were sold at an average price of $20.08, for a total value of $140,560.00. Following the sale, the insider now directly owns 164,543 shares of the company’s stock, valued at $3,304,023.44. The disclosure for this sale can be found here. Corporate insiders own  59.40% of the company’s stock. ', 'R1 RCM Company Profile', 'R1 RCM, Inc engages in the provision of revenue cycle management to healthcare providers. It offers end-to-end, modular revenue cycle, and physician advisory services. The company was founded by Mary Ann Tolan and J. Michael Cline in July 2003 and is headquartered in Chicago, IL. ', 'Recommended Story: Example of operating income, EBIT and EBITDA', '', '', "Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with MarketBeat.com's FREE daily email newsletter.", 'HubSpot, Inc. (NYSE:HUBS) Stock Holdings Lessened by Lisanti Capital Growth LLC']


